research
Beyond Weight Loss: What the WHO's Latest Reviews Reveal About GLP-1 Drugs
Three WHO-commissioned systematic reviews analyzed GLP-1 drugs across 44,000+ participants. The findings go well beyond the scale. Here's what matters.
2 articles tagged with "semaglutide"
Three WHO-commissioned systematic reviews analyzed GLP-1 drugs across 44,000+ participants. The findings go well beyond the scale. Here's what matters.
GLP-1 medications like Ozempic increase muscle loss risk. Learn the protein timing strategy that protects lean mass while maximizing fat loss.